Epilepsy Study

Biohaven BHV7000 Rise Focal Epilepsy Study About the study? A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety, and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy. Purpose of the study? If you or a loved one have been diagnosed with focal onset epilepsy, are between the ages of […]